Evidence map›Paper›PMID 35225146›Full record

ArticlePharmaceutical biology2022

Protective role of crocin against sepsis-induced injury in the liver, kidney and lungs via inhibition of p38 MAPK/NF-κB and Bax/Bcl-2 signalling pathways.

Jun Gao, Feng Zhao, Shaona Yi, Shuhang Li, Aiqing Zhu, Yingxiu Tang, Aiqun Li

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Study on the mechanism of Shenmai injection in the treatment of sepsis.Journal of cellular and molecular medicine · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jun GaoDepartment of Laboratory Medicine, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, China.
Feng ZhaoDepartment of Nephrology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, China.
Shaona YiDepartment of Nephrology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, China.
Shuhang LiDepartment of Urology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, China.
Aiqing ZhuDepartment of Dermatology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, China.
Yingxiu TangDepartment of Laboratory Medicine, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, China.
Aiqun LiDepartment of Emergency, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, China.
Binzhou University · CNBinzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextCrocin has been reported to have multiple bioactivities. However, the effect of crocin administration on caecal ligation and puncture (CLP)-induced sepsis remains unknown.

objectiveWe investigated the effects of crocin on CLP-induced sepsis in mice and the underlying mechanism of action. MATERIALS AND

methodsFive experimental groups (

resultsCompared to the CLP group, crocin treatment significantly increased the survival rate (70%, 80%, 90% vs. 30%). Crocin groups exhibited protection against liver, kidney and lung damage with mild-to-moderate morphological changes and lower indicator levels: liver (2.80 ± 0.45, 2.60 ± 0.55, 1.60 ± 0.55 vs. 5.60 ± 0.55), kidney (3.00 ± 0.71, 2.60 ± 0.55, 1.40 ± 0.55 vs. 6.20 ± 0.84) and lungs (8.00 ± 1.59, 6.80 ± 1.64, 2.80 ± 0.84 vs. 14.80 ± 1.79). The proinflammatory cytokines (IL-1β, TNF-α, IL-6 and IL-10 levels in the crocin groups) were distinctly lower and the apoptotic index showed a significant decrease. Crocin administration significantly suppressed p38 MAPK phosphorylation and inhibited NF-κB/IκBα and Bcl-2/Bax activation. DISCUSSION AND

conclusionsPre-treatment with crocin confers protective effects against CLP-induced liver, kidney and lung injury, implying it to be a potential therapeutic agent.

Indexed as

Animalsbcl-2-Associated X ProteinCarotenoidsDisease Models, AnimalDose-Response Relationship, DrugKidney DiseasesLiver DiseasesLung DiseasesMiceMice, Inbred BALB CNF-kappa Bp38 Mitogen-Activated Protein KinasesProto-Oncogene Proteins c-bcl-2SepsisBax protein, mousebcl-2-Associated X ProteinBcl2 protein, mouseCarotenoidscrocinNF-kappa Bp38 Mitogen-Activated Protein KinasesProto-Oncogene Proteins c-bcl-2antiapoptoticAnti-inflammatoryantioxidantorgan

Identifiers

PMID35225146
PMCPMC8890572
OpenAlexW4214548707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.